Noxopharm Limited
ASX:NOX.AX
0.078 (AUD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -3.578 | -15.056 | -18.667 | -9.347 | -0.272 | -11.223 | -18.284 | -3.046 | -0.705 |
| Depreciation & Amortization
| 0 | 0.155 | 0.262 | 0.262 | 0.241 | 0.062 | 0.059 | 0.03 | 0.003 |
| Deferred Income Tax
| 0 | -0.73 | -6.319 | 1.146 | -4.572 | -1.434 | -8.132 | 0 | -0.175 |
| Stock Based Compensation
| 0 | 0.012 | 0.804 | 1.742 | 0.312 | 0.899 | 9.461 | 0 | 0.023 |
| Change In Working Capital
| 3.735 | -0.591 | -5.071 | 3.602 | -3.627 | 0.535 | -1.329 | 0.1 | 0.152 |
| Accounts Receivables
| 3.702 | -0.477 | 0.177 | -1.14 | -4.723 | -0.038 | -0.06 | 0.024 | -0.039 |
| Inventory
| 0 | 1.146 | -0.835 | 0.208 | 0.177 | 0.573 | -1.269 | 0 | 0 |
| Accounts Payables
| 0 | -1.079 | -4.334 | 4.343 | 0.767 | 0.6 | 0.597 | 0.017 | -0.106 |
| Other Working Capital
| 0.033 | -0.181 | -0.078 | 0.19 | 0.151 | -0.6 | -0.597 | 0.059 | 0.297 |
| Other Non Cash Items
| -0.841 | 5.265 | 15.259 | -6.255 | -3.22 | 1.385 | 9.149 | -0.002 | -0.023 |
| Operating Cash Flow
| -0.684 | -10.946 | -13.734 | -8.85 | -11.138 | -9.776 | -9.076 | -2.918 | -0.55 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | -0.003 | -0.006 | -0.312 | -0.079 | -0.02 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0.341 | 0.003 | 0 | 0.002 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.077 | 0 |
| Sales Maturities Of Investments
| 0 | 0.124 | 0 | 0 | 0 | 0 | 0 | -0.002 | 0 |
| Other Investing Activites
| 0 | 0.124 | 0 | 0.225 | 0.341 | 0.003 | 0 | -0.119 | 0 |
| Investing Cash Flow
| 0 | 0.124 | 0 | 0.225 | 0.338 | -0.003 | -0.312 | -0.273 | -0.02 |
| Financing Activities: | |||||||||
| Debt Repayment
| 2 | 0 | 0 | 0 | 4.112 | 0 | 3.803 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 1.205 | 28.569 | 10.221 | 0.075 | 15.74 | 6 | 0.731 |
| Common Stock Repurchased
| 0 | 0 | 0 | -1.528 | -0.786 | 0 | -1.187 | -0.512 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -2 | -0.178 | -0.229 | -0.245 | 10.879 | 0 | 15.74 | 0 | 0 |
| Financing Cash Flow
| 0 | -0.178 | 0.976 | 28.324 | 14.991 | 0.075 | 19.544 | 5.488 | 0.731 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| -0.004 | -0.001 | -0.027 | -0.004 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -0.689 | -11.002 | -12.785 | 19.696 | 4.191 | -9.704 | 10.156 | 2.297 | 0.161 |
| Cash At End Of Period
| 2.32 | 3.009 | 14.011 | 26.796 | 7.1 | 2.91 | 12.614 | 2.458 | 0.161 |